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Abstract
We investigated the mechanisms of excitation-contraction (EC) coupling in human embryonic stem cell-derived
cardiomyocytes (hESC-CMs) and fetal ventricular myocytes (hFVMs) using patch-clamp electrophysiology and confocal
microscopy. We tested the hypothesis that Ca
2+ influx via voltage-gated L-type Ca
2+ channels activates Ca
2+ release from
the sarcoplasmic reticulum (SR) via a local control mechanism in hESC-CMs and hFVMs. Field-stimulated, whole-cell [Ca
2+]i
transients in hESC-CMs required Ca
2+ entry through L-type Ca
2+ channels, as evidenced by the elimination of such transients
by either removal of extracellular Ca
2+ or treatment with diltiazem, an L-type channel inhibitor. Ca
2+ release from the SR also
contributes to the [Ca
2+]i transient in these cells, as evidenced by studies with drugs interfering with either SR Ca
2+ release
(i.e. ryanodine and caffeine) or reuptake (i.e. thapsigargin and cyclopiazonic acid). As in adult ventricular myocytes,
membrane depolarization evoked large L-type Ca
2+ currents (ICa) and corresponding whole-cell [Ca
2+]i transients in hESC-
CMs and hFVMs, and the amplitude of both ICa and the [Ca
2+]i transients were finely graded by the magnitude of the
depolarization. hESC-CMs exhibit a decreasing EC coupling gain with depolarization to more positive test potentials, ‘‘tail’’
[Ca
2+]i transients upon repolarization from extremely positive test potentials, and co-localized ryanodine and sarcolemmal L-
type Ca
2+ channels, all findings that are consistent with the local control hypothesis. Finally, we recorded Ca
2+ sparks in
hESC-CMs and hFVMs. Collectively, these data support a model in which tight, local control of SR Ca
2+ release by the ICa
during EC coupling develops early in human cardiomyocytes.
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Introduction
Human embryonic stem cells (hESCs) can be induced to
differentiate in vitro into cardiomyocytes (hESC-CMs). These cells
express expected cardiac markers and exhibit spontaneous action
potentials (APs), [Ca
2+]i transients, and contractile activity. At
present, however, the mechanisms underlying excitation-contrac-
tion (EC) coupling in hESC-CMs are incompletely understood.
Addressing this issue is critical for two fundamental reasons. First,
hESC-CMs represent a unique model system in which to study the
development of EC coupling in early human myocardium. Second,
because of their tremendous expandability and unquestioned
cardiac potential, hESC-CMs have considerable promise for
eventual application in cell-based cardiac repair (for review, see
refs [1,2]). However, because hESC-CMs should be well-matched
to host adult human ventricular myocardium to optimize host-
graft electromechanical integration and minimize the risk of
arrhythmias, the development of any cell therapies based on
hESC-CMs must be preceded by a thorough investigation of the
biophysical properties of these cells.
UnlikeinhESC-CMs,the mechanismsunderlyingECcoupling in
mammalian adult ventricular myocytes have been the subject of
intense investigation for many years and so are comparatively
well-understood (for review, see refs [3,4]). Studies with adult
cardiomyocytes have led to the formulation of the local control
model of ECcoupling[5–9].In thismodel,briefopeningsofvoltage-
gated L-type Ca
2+ channels during the AP allow a small amount of
Ca
2+ to enter the cardiac cytoplasm. This Ca
2+ influx causes a local
[Ca
2+]i increase that rapidly (,1 ms) activates nearby sarcoplasmic
reticulum (SR) Ca
2+ release channels (i.e. ryanodine receptors,
RyRs) by the mechanism of Ca
2+-induced Ca
2+ release (CICR) [10].
The simultaneous activation of a small number of RyRs allows Ca
2+
stored in the lumen of the SR to flow into the cardiomyocyte
cytoplasm causing a local increase in [Ca
2+]i. These local Ca
2+
release events, termed ‘Ca
2+ sparks’, are considered the elementary
Ca
2+ release events of EC coupling[6]. Ca
2+ sparks can occur
spontaneously, or they can be activated by the L-type Ca
2+ current
(ICa) [5,11,12]. During the AP, activation of ICa synchronizes the
activation of multiple Ca
2+ sparks, which sum to produce a large,
whole-cell [Ca
2+]i transient. As ICa inactivates, the probability of
activation of Ca
2+ sparks diminishes, thereby allowing the SR Ca
2+
ATPase and Na
+-Ca
2+ exchanger to return the [Ca
2+]i to resting
levels [13]. A central tenet of this model is that the amplitude of the
[Ca
2+]i is graded by the amplitude of ICa [8].
Although the mechanisms underlying EC coupling in hESC-
CMs are incompletely understood, in principle one can envision
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whole-cell [Ca
2+]i transient during an AP in these cells. Model 1
involves a mechanism similar to that of turtle [14], frog [15], and
dogfish [16] ventricular myocytes as well as primary embryonic
murine cardiomyocytes [17], in which [Ca
2+]i transients result
solely from Ca
2+ influx via ICa during the AP. In model 2,C a
2+
influx via L-type Ca
2+ channels activates SR Ca
2+ release via
CICR during an AP. However, in this model, the strength of the
functional coupling between L-type Ca
2+ channels and RyRs
could be weak or variable [18]. In model 3, global [Ca
2+]i transient
are produced by spontaneous release from intracellular stores,
without the activation of L-type Ca
2+ channels. This model has
been reported to hold for EC coupling in primary murine
embryonic cardiomyocytes and cardiomyocytes from murine
ESCs [19–22]. Finally, model 4 is similar to the one described
above for adult ventricular myocytes, which involves tight, local
coupling between Ca
2+ influx and SR Ca
2+ release during EC
coupling.
In this study, we examined the mechanisms of EC coupling in
hESC-CMs, as well as in ,100 day old human fetal ventricular
myocytes (hFVMs), which serve as a useful comparison cell type of
known age. Using a variety of techniques including fluorescent
Ca
2+ imaging, voltage-clamp studies, and confocal immunofluo-
rescence microscopy, we demonstrate that EC-coupling in both
cell types involves Ca
2+ influx via dihydropyridine-sensitive,
voltage-gated L-type Ca
2+ channels, which results in SR Ca
2+
release via a tight, local mechanism akin to that exhibited by
mature ventricular cardiomyocytes (i.e. model 4 above).
Materials and Methods
Differentiation of hESC-CMs
For all experiments, H7 hESCs [23] were differentiated into
cardiomyocytes using our recently reported directed cardiac
differentiation protocol [24]. In brief, hESCs were expanded in
the undifferentiated state on Matrigel (BD Biosciences, San Jose,
CA) coated substrates using mouse embryonic fibroblast condi-
tioned medium (MEF-CM) [25]. Prior to induction of cardiogen-
esis, hESCs were enzymatically dispersed, replated onto Matrigel-
coated surfaces in a high-density monolayer culture, and then
maintained for an additional 6 days in MEF-CM. To induce
cardiac differentiation, MEF-CM is replaced by RPMI-B27
medium (Invitrogen, Carlsbad, CA) supplemented with the
following cytokines: 100 ng/ml human recombinant activin A
(R&D Systems, Minneapolis, MN) for 24 hours, followed by
10 ng/ml human recombinant bone morphogenenetic protein-4
(BMP-4, R&D Systems) for 4 days. This medium is then
exchanged for RPMI-B27 without supplementary cytokines on
every second day for an additional 10 days. Widespread
spontaneous beating activity is typically observed by 9–12 days
following induction with activin A. On day 14 post-induction, cells
are enzymatically dispersed (with dispase) and re-plated onto
polyethylenimine- and gelatin-coated glass coverslips for calcium
imaging, electrophysiological recordings, or immunofluorescence
3–7 days later. We routinely immunostained comparably prepared
cultures and, consistent with our prior report describing this
method [24], found the majority of resultant cells to be comprised
of cardiomyocytes (5968% positive for the striated muscle marker
sarcomeric actin, data not shown).
Dissociation of human fetal ventricular myocytes
Human fetal hearts (90–110 days gestational age) were obtained
from the University of Washington Birth Defects Research
Laboratory under a waiver from the University’s Institutional
Review Board (IRB) for Human Subjects. The IRB determined
that this work, which involved anonymous human biological
materials received from this depository, is not considered human
subjects research (IRB Determination # 08-0062-N). The NIH-
funded Birth Defects Research Laboratory tissue distribution
program has been separately approved by the IRB (approval #96-
1825-A13) and operates in fully compliance with all relevant state
and federal laws and regulations. All donors provide written
informed consent prior to donating tissues to this depository, and
all donated tissues would otherwise be discarded. Ventricular
myocytes were then dissociated from these fetal hearts using
enzymatic methods modified from those described by Ufret-
Vincenty et al. [26]. In brief, after transport in ice-cold DMEM,
each heart was retrogradely perfused with oxygenated Ca
2+-free
Tyrode’s solution (37uC, pH 7.4) for 5 minutes, followed by a
switch to a solution also containing 1% collagenase I (Worthington
Biochemical, Lakewood, NJ), 0.01% protease, and 0.08 mM
CaCl2. After approximately 10 minutes of digestion, the left
ventricular tissue was removed, minced and filtered through nylon
mesh. The resultant dissociated ventricular myocytes were
maintained in Dulbecco’s MEM at 25uC for up to 4 hours before
use.
Ca
2+ imaging
We measured changes in [Ca
2+]i using the fluorescent Ca
2+
indicator Fluo-4 (Molecular Probes, Eugene, OR). For experi-
ments that involved the simultaneous measurement of electro-
physiological signals and [Ca
2+]i, cells were loaded with the penta-
potassium salt of Fluo-4 (50 mM) through the patch pipette. For
measurements of [Ca
2+]i that did not involved patch-clamping (i.e.
Ca
2+ sparks, SR Ca
2+ load in paced and un-stimulated cells),
myocytes were loaded with the membrane permeable acetox-
ymethyl-ester form of Fluo-4 (Fluo-4 AM) as previously described
[27]. Coverslips containing the dye-loaded hESC-CMs or hFVMs
were mounted in a chamber and superfused at a rate of 1 ml/min
with solution A (see Table 1 below) at 25 uC.
Confocal imaging of whole-cell [Ca
2+]i and Ca
2+ sparks was
performed using a BioRad Radiance 2000 or Nikon Swept Field
confocal system (Cambridge, MA, USA) coupled to a Nikon
TE300 inverted microscope equipped with a Nikon 606 oil
immersion lens (NA=1.4). Images were analyzed with custom
Table 1. Composition of solutions used.
Bath Solutions Pipette Solution
AB C
NaCl 140 140 -
KCl 5.4 - -
CaCl2 1.8 2.0 -
MgCl2 1.0 1.0 -
CsCl - 5 130
NaH2PO4 0.33 - -
HEPES 10 10 10
Glucose 5 10 -
TTX - 0.01 -
TEA-Cl - - 10
Mg-ATP - - 5
All values are expressed in mM.
doi:10.1371/journal.pone.0005407.t001
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CO, USA). Ca
2+ sparks were identified using a computer
algorithm similar to the one described by Cheng et al.[28]. The
amplitude of the [Ca
2+]i transient evoked by the application of a
Ca
2+- and Na
+-free (substituted with N-methyl-D-glucamine)
solution containing 20 mM caffeine (1 s; via a picospritzer) was
used as an indicator of SR Ca
2+ content [29]. To ensure steady-
state SR Ca
2+ load, cells were subjected to a minimum of 10
preconditioning pulses (1 Hz) before caffeine was applied.
Calibration of fluorescence signals was performed using the
‘pseudo-ratio’ equation [6].
Patch-clamp electrophysiology
ICa was elicited at 1 Hz and recorded using an Axopatch 200B
patch-clamp amplifier (Axon Instruments, Union City, CA)
operated in voltage-clamp mode. During ICa recordings, cells
were superfused with solution B (see Table 1 below) at 25u C. The
pipette solution used in these experiments was solution C (also in
Table 1). To inactivate the fast sodium current, cells were
depolarized via a 500 ms duration ‘‘ramp’’ from a holding
potential of 270 mV to 250 mV and then held at the latter
potential for an additional 200 msec. To activate ICa, cells were
next depolarized with a 200 ms duration step from 250 mV to
any of range of voltages from 240 to +100 mV. For some
experiments, [Ca
2+]i transients were simultaneously recorded either
during the depolarization step or after repolarization to a 270 mV
holding potential, using the techniques detailed in the preceding
section. The whole-cell capacitance was determined using the
charging time (‘RC’) constant that resulted from 5 mV depolarizing
pulses from a holding potential of 270 mV. The capacitance of
hESC-CMs and hFVMs measured 24.663.3 pF (n=15) and
20.364.6 pF (n=6), respectively. The series resistance compensa-
tion circuitry of the Axopatch 200B was used in all voltage-clamp
experiments to compensate for about 60% of the series resistance.
Signals were digitized and stored on a computer running the
pCLAMP 8 software suite (Axon Instruments), and analysis of
electrophysiological records was performed using the CLAMPFIT
module of pCLAMP 8. ICa was normalized to cell capacitance.
Field-stimulation
Field stimulation was performed via two platinum wires (0.5 cm
separation) placed at the bottom of a customized perfusion
chamber. An IonOptix Myopacer (IonOptix Corp, Milton, MA,
USA) stimulator was used to deliver square voltage pulses (4 ms
duration) with amplitude of 1.56threshold at a frequency of 1 Hz.
Immunocytochemistry
Immunostaining was performed as previously described [24,30],
using antibodies directed against the RyR2 channel (mouse
monoclonal antibody, Affinity Bioreagents, Rockford, IL, used at
a 1:1000 dilution) and Cav1.2, the a1c subunit of the L-type Ca
channel (rabbit polyclonal antibody, Sigma, used at a 1:500
dilution). In brief, cells were fixed with 2% paraformaldehyde,
permeabilized with the addition of 0.1% Triton X-100 in
phosphate-buffered saline (PBS) for 10 minutes, quenched in an
isotonic solution of 50 mM glycine in diluted PBS for 10 minutes,
and then blocked with 1.5% normal goat serum in PBS at 4u C
overnight. The aforementioned primary antibodies were then
applied serially (each overnight at 4u C, also in 1.5% normal goat
serum in PBS), followed by detection with either an Alexa-488-
conjugated goat anti-mouse or Alexa-594-conjugated goat anti-
rabbit secondary antibody (Molecular Probes, Eugene, OR).
Images were acquired using the Nikon Swept Field confocal
system described above with a 1006 (1.49 NA) lens. Alexa-488
and Alexa-594 were excited with the 488 nm and 561 nm laser
lines of this system. Fluorescence emission signals from these
indicators were collected sequentially and separated using
appropriate filter sets. Images were collected at 0.25 mm intervals
in the z-axis. Co-localization analysis and volumetric reconstruc-
tions of confocal three-dimensional images stacks were performed
using Elements software (Nikon).
Statistics
All data groups were submitted to a D’Agostino & Pearson
omnibus test to determine whether they had a normal (i.e. bell-
shaped) distribution. Parametric data are presented as mean6-
standard error of the mean (SEM). Non-parametric data are
presented as median and range. Two-sample comparisons were
made using a Mann-Whitney or Student’s t-test. A p value less
than 0.05 was considered significant. Asterisks (*) used in the
figures indicate a significant difference between groups.
Results
Ca
2+ influx via L-type Ca
2+ channels is required for
evoking whole-cell [Ca
2+]i transients in hESC-CMs
We investigated whether Ca
2+ influx was required for the
development of a global [Ca
2+]i transient during EC coupling in
hESC-CMs. APs were evoked via field stimulation (1 Hz). [Ca
2+]i
was recorded in cells loaded with the fluorescent Ca
2+ indicator
fluo-4 using confocal microscopy (see Methods and Materials
section above for details). Under control conditions (i.e. 1.8 mM
external Ca
2+), APs evoked large, cell-wide [Ca
2+]i transients in
hESC-CMs (Figure 1). The average amplitude of these [Ca
2+]i was
4.660.4 F/F0 (n=19 cells). [Ca
2+]i rose in hESC-CMs after
activation of the AP: the time-to-peak of the evoked [Ca
2+]i
transient was 150625 ms. Analysis of the decaying phase of the
[Ca
2+]i transient revealed the time it took to decay to 50%
amplitude of its amplitude (T50) was 245645 ms. Note that the
time-to-peak and T50 of the [Ca
2+]i transients in hESC-CMs are
similar to those reported for [Ca
2+]i transients in adult human
ventricular myocytes [31]. Removal of external Ca
2+ eliminated
AP-evoked [Ca
2+]i transients in hESC-CMs, demonstrating a
requirement for Ca
2+ influx during EC coupling in these cells
(Figure 1A and 1B).
We next tested the hypothesis that Ca
2+ influx via L-type Ca
2+
channels is required for activation of the [Ca
2+]i transient during
an AP in hESC-CMs (Figure 1C). To do this, [Ca
2+]i transients
were recorded in hESC-CMs before and after the application of
the L-type Ca
2+ blocker diltiazem (10 mM, n=9 cells). Consistent
with our hypothesis, diltiazem (10 mM) eliminated the [Ca
2+]i
transient in these cells (Figure 1C). Together with the external
Ca
2+ experiments described above, these findings indicate that
activation of L-type Ca
2+ channels during an AP allows Ca
2+
influx thus inducing a global increase in [Ca
2+]i in hECM-CMs.
Thus, these data are consistent with models 1, 2, and 4 discussed in
the Introduction section above.
SR Ca
2+ release amplifies Ca
2+ influx during EC coupling
in hESC-CMs
We examined the role of SR Ca
2+ release during EC coupling in
hESC-CMs by recording [Ca
2+]i transients in these cells before
and after the application of the irreversible SR Ca
2+ATPase
(SERCA) inhibitor thapsigargin (1 mM) (Figure 2A and B).
Thapsigargin treatment decreased the amplitude of the evoked
[Ca
2+]i transient to 21610% of control (n=7; p,0.05). We next
repeated this experiment using the reversible SERCA inhibitor
cyclopiazonic acid (CPA, 10 mM). Figure 2C shows AP-evoked
EC Coupling in ESC-Cardios
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2+]i transients from a representative hESC-CM under control
conditions, during CPA treatment, and after the SERCA pump
inhibitor was washed out. CPA decreased [Ca
2+]i transient
amplitude to 30610% (n=7; p,0.01), but this effect was partially
reversed following drug washout (to 5769% of baseline, n=7;
p,0.01). Taken collectively with the data in Figure 1 (see above),
these findings indicate that SR Ca
2+ release amplifies the Ca
2+
influx via L-type Ca
2+ channels and is a major contributor of Ca
2+
during the evoked global [Ca
2+]i transient during EC coupling.
Graded activation of ICa and [Ca
2+]i transients by
membrane potential in hESC-CMs and hFVMs
Having ruled out the possibility that Ca
2+ influx is by itself
sufficient to produce the [Ca
2+]i transients observed in hESC-CMs
(i.e. model 1 discussed in the Introduction), we investigated
whether L-type Ca
2+ channels activate SR Ca
2+ release during EC
coupling through a loose (i.e. model 2 above) or a tight, local control
mechanism (i.e. model 4 above). If SR Ca
2+ release in hESC-CMs is
activated by local Ca
2+ signals produced by closely apposed L-type
Ca
2+ channels, one would expect the amplitude of the [Ca
2+]i to
Figure 1. External Ca
2+ influx via L-type Ca
2+ channels is
required for EC coupling in hESC-CMs. A. Confocal line-scan
images from a representative, field-stimulated hESC-CM under control
conditions (i.e. 1.8 mM external Ca
2+, upper image) and after the
application of a Ca
2+-free solution (lower). B. Corresponding [Ca
2+]i
transients under control (black trace) and Ca
2+-free (red) conditions. C.
[Ca
2+]i transients before (black) and after the application of the L-type
Ca
2+ channel blocker diltiazem (10 mM, red).
doi:10.1371/journal.pone.0005407.g001
Figure 2. Thapsigargin decreases [Ca
2+]i transients in hESC-
CMs. A. Time-course of field-stimulated [Ca
2+]i transients in a
representative hESC-CM under control conditions (black trace) and
after exposure to thapsigargin (1 mM, red). B. Bar graph describing the
percentage change in the peak of the [Ca
2+]i transient before (control,
black) and after (red) exposure to thapsigargin in hESC-CMs. C. Time-
course of field-stimulated [Ca
2+]i transients in a representative hESC-CM
under control conditions (black), during exposure to 10 mM cyclopia-
zonic acid (CPA, red), and following washout of CPA (blue).
doi:10.1371/journal.pone.0005407.g002
EC Coupling in ESC-Cardios
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hand, if SR Ca
2+ release in hESC-CMs is activated by Ca
2+ signals
of variable strength (as would be expected with variations in the
relative location of RyRs and L-type Ca
2+ channels) or by
spontaneous SR Ca
2+ release alone (i.e. model 3 above), there
would be a poor correlation between the amplitude of ICa and the
associated [Ca
2+]i transient in these cells. To determine which of
these potential scenarios apply to hESC-CMs, we simultaneously
recorded ICa and [Ca
2+]i in hESC-CMs during step depolariza-
tions (200 ms duration) from the holding potential of 250 mV to
test potentials ranging from 240 to +60 mV (Figure 3). We also
obtained ICa and [Ca
2+]i transient recordings from hFVMs, which
allowed us to compare our hESC-CM data with that from a
human cardiomyocyte of a known (i.e. ,100 days gestational age)
and presumably more advanced developmental stage.
Membrane depolarization evoked large ICa and global [Ca
2+]i
transients in hESC-CMs and hFVMs. The amplitude of ICa and
the associated [Ca
2+]i transient varied with the magnitude of the
test membrane potential in both cell types (Figure 3). Interestingly,
the amplitude of ICa and the [Ca
2+]i transient were remarkably
Figure 3. Voltage dependencies of ICa and [Ca
2+]i during EC coupling in hESC-CMs and hFVMs. A. ICa traces from typical hESC-CMs and
hFVMs. ICa was evoked elicited using the voltage protocol depicted in the inset to the right. In brief, cells were slowly depolarized from the holding
potential of 270 mV to 250 mV, where they were held to inactivate the Na
+ current. Cells were then depolarized from 250 mV to test potentials
ranging from 240 to +60 mV for 200 ms. B. Current-voltage relationships of ICa in hESC-CMs (red) and hFVMs (black). C. [Ca
2+]i transients evoked by
ICa following depolarization to 240, 0, +40 mV in representative hESC-CMs and hFVMs. D. Voltage-dependence of the amplitude of the [Ca
2+]i
transient in hESC-CMs and hFVMs. E. Voltage-dependence of the EC coupling gain factor in hESC-CMs and hFVMs.
doi:10.1371/journal.pone.0005407.g003
EC Coupling in ESC-Cardios
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examined. At 0 mV, ICa density was 9.161.7 (n=7 cells) and
11.661.6 (n=6 cells; p=0.067) pA/pF in hESC-CMs and
hFVMs, respectively. The amplitude of the [Ca
2+]i transient at
the same potential was 1097697 and 902677 nM (p=0.15) in
hESC-CMs and hFVMs, respectively.
Moreover, as previously reported in adult ventricular myocytes
[32,33], the voltage dependencies of ICa (Figure 3B) and the
[Ca
2+]i transients (Figure 3C) were bell-shaped, gradually
increasing in amplitude as the cell was depolarized from 240 to
0 mV. Depolarization to more positive potentials (.0 mV) evoked
progressively smaller ICa and [Ca
2+]i transients, likely due to a
reduction in the driving force for Ca
2+ influx. To quantify changes
in the sensitivity of the SR to the trigger ICa, we calculated the EC
coupling ‘‘gain’’ (defined as the ratio of the [Ca
2+]i transient
amplitude to the ICa current density [12,34]) elicited with each
voltage step. One of the predictions of the local control hypothesis
(i.e. model 4) is that this gain factor will be high at negative
potentials (e.g. 240 mV, where ICa is small, but the driving force
for Ca
2+ entry via single L-type Ca
2+ channels is large) but will
decrease with depolarization to increasingly positive test potentials
(e.g. 0 mV, where ICa amplitude is maximal, but the amplitude of
unitary L-type Ca
2+ current is comparatively small). This
prediction holds true in mammalian adult ventricular myocytes
[5,12,34], and we found that it also applies to hESC-CMs and
hFVMs (Figure 3E).
When adult ventricular are depolarized to highly positive test
potentials close to the Nernst equilibrium potential for Ca
2+
(,+120 mV), L-type Ca
2+ channels open, but the Ca
2+ influx
through these channels is low due to a weak driving force.
However, upon repolarization from such extremely positive test
potentials (e.g. repolarization from +100 mV to 270 mV), there is
a rapid increase in driving force, and a ‘‘tail’’ ICa is evoked.
Because L-type Ca
2+ channels deactivate rapidly (t of deactiva-
tion,1 ms), these tail ICa currents are short-lived. In adult
ventricular myocytes, tail ICa currents can also induce [Ca
2+]i
transients, a phenomenon that has been attributed to CICR
initiated by the Ca
2+ influx during repolarization [32,35,36]. The
exhibition of tail [Ca
2+]i transients is considered strong evidence
for the local control hypothesis, as the extremely brief tail ICa is
thought to allow only a small amount of Ca
2+ influx and so is only
able to activate RyRs within a tight, local domain. The presence of
tail [Ca
2+]i transients also distinguishes cardiac-type EC coupling
from that in skeletal muscle, which operates on a charge-coupled
mechanism and so repolarization does not elicit SR Ca
2+ release
[37]. We found that hESC-CMs exhibited robust tail [Ca
2+]i
transients in response to repolarization to 270 mV following a
voltage step to +100 mV (Figure 4A). Of note, both these tail
[Ca
2+]i transients and [Ca
2+] transients elicited during a voltage
step to peak ICa (i.e. a test potential of 0 mV) were largely
eliminated by treatment with ryanodine (10 mM), an effect that
indicates a significant contribution by release from RyR-gated SR
Ca
2+ stores (Figure 4B). In particular, ryanodine reduced the
amplitude of tail [Ca
2+]i transients (evoked by repolarization from
+100 mV to 270 mV) from a baseline of 945637 nM to
250610 nM, and it reduced the amplitude of [Ca
2+] transients
(evoked by a depolarizing step to 0 mV) from 853652 nM to
26968 nM (n=6 cells per condition).
Collectively, these data indicate that Ca
2+ release from the SR is
graded by the amplitude of ICa, likely via local Ca
2+ signaling
between closely apposed L-type Ca
2+ channels and RyRs in
hESC-CMs (i.e. model 4).
Figure 4. Tail [Ca
2+]i transients in hESC-CMs. A. [Ca
2+]i traces from a representative hESC-CMs during a 200 ms step depolarization from
240 mV to a test potential of 0 mV (left) or +100 mV (right), followed by a repolarization to 270 mV. Note the large tail [Ca
2+]i transient evoked by
repolarization from +100 mV in the record to the right. B. Corresponding [Ca
2+]i traces elicited by the same voltage protocols after treatment with
ryanodine (10 mM).
doi:10.1371/journal.pone.0005407.g004
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2+
channels in hESC-CMs
Another testable prediction of the local control model of EC
coupling is that L-type Ca
2+ channels (Cav1.2) and ryanodine
receptors (RyRs) are co-localized within specific domains near the
sarcolemma. To test this hypothesis in hESC-CMs, we examined the
subcellular distribution of type 2 RyRs (RyR2s) and L-type Ca
2+
channels in hESC-CMs using confocal immunofluorescence ap-
proaches. As illustrated by Figure 5A, we observed punctate
immunoreactivity for L-type Ca
2+ channels throughout the sarco-
lemma of hESC-CMs. Interestingly, L-type Ca
2+ channels (red) and
RyR2s (green) were co-localized within small clusters near the surface
of the cell (Figure 5B). The diameter at 50% amplitude of L-type
Ca
2+ channels and RyR2 clusters was 1.260.1 mm( n = 5 5 )a n d
1.060.1 mm (n=41), respectively. We performed quantitative co-
localization analysis of L-type Ca
2+ and RyR2-associated fluores-
cence on a pixel-by-pixel basis. The statistical significance of the co-
localization of these two proteins is supported by Mander’s overlap
and Pearson correlation values of +0.88 and +0.83, respectively.
These data indicate that L-type Ca
2+ channels are co-localized with
RyR2s within small sarcolemmal clusters in hESC-CMs.
Spontaneous Ca
2+ sparks in hESC-CM and hFVMs
To better understand the mechanisms underlying Ca
2+ release
from the SRof hESC-CMs and hFVMs, we asked whetherthese cell
types exhibit Ca
2+ sparks, the elementary release events during EC-
coupling. In fact, spontaneous Ca
2+ sparks were routinely observed
in both hESC-CMs and hFVMs. Representative sparks and
associated parameters from both cell types are depicted in Figure 6,
and a summary of our comparative analysis of Ca
2+ sparks in these
cells is presented in Table 2. The width at 50% peak amplitude and
T50 were similar in both cell types (p.0.05, n=36 in hESC-CMs,
n=86 in hFVMs). Interestingly, however, the Ca
2+ spark rate
(defined as the number of Ca
2+ sparks per sec per cell) was nearly
four-fold higher in hFVMs (n=7) than in hESC-CMs (n=10;
p,0.01).Ca
2+ sparkamplitudeand time-to-peakwerealsogreater in
hFVMs (n=86 events) than in hESC-CMs (n=36 events, p,0.05).
Finally, because SR Ca
2+ load modulates Ca
2+ spark activity
[38], we also examined this parameter in hESM-CMs and
hFVMs, using the amplitude of a caffeine-induced [Ca
2+]i
transient as an indicator of SR Ca
2+ load (Figure 7). To ensure
steady-state SR Ca
2+ loading, caffeine (20 mM) was applied after
conditioning each cell with a train of ten APs. We found that the
amplitude of the caffeine-induced [Ca
2+]i transient was higher in
hFVMs (6.360.3 F/F0, n=6) than in hESC-CMs (5.860.3 F/F0,
n=8, p=0.004), suggesting that steady-state SR Ca
2+ load is
greater in hFVMs than in hESC-CMs.
Discussion
In adult ventricular myocytes, activation of SR Ca
2+ release
during the AP occurs at special structures named Ca
2+ release
Figure 5. Immunofluorescent co-localization of RyR2 and L-type Ca
2+ channels in hESC-CMs. A. Volumetric view of a stack of confocal
anti-Cav1.2 images from a representative hESC-CM. Images were collected every 0.25 mm in the z-axis. The scale bars in the image indicate 5, 2, and
5 mm along the x, y, and z-axes, respectively. The horizontal grey boxes show the location of the two optical sections depicted in panel B. B. Two-
dimensional anti-RyR2 (green, left), anti-L-type Ca
2+ channels (anti-Cav1.2, red, center), and merged images, corresponding to optical sections 1 and 2
from panel A. Note that the merged image from optical section 1 includes two dotted lines, one that runs along the cell membrane (magnified in the
inset) and one that traverses the cell. The corresponding plots to the right indicate the two-channel fluorescent intensity along each of the
aforementioned lines.
doi:10.1371/journal.pone.0005407.g005
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2+ channels are in close proximity
(about 10–12 nm) to RyRs in the junctional SR [39]. The
cytosolic volume in this junctional space is small. Brief openings
(,1 ms) of L-type Ca
2+ channels in these regions of the cell allow
enough Ca
2+ influx to produce a local, junctional increase in
[Ca
2+]i (10–100 mM) to activate nearby RyRs via CICR, resulting
in Ca
2+ sparks [40–42]. The local control model of EC coupling
holds that, under physiological conditions, the activation of any
given CRU does not activate nearby release units because RyRs
are relatively insensitive to Ca
2+ and [Ca
2+]i does not reach high
enough levels in neighboring sites to induce their activation. This
prevents the regenerative, all-or-none [Ca
2+]i transient that would
be predicted by a global control mechanism. Instead, the
amplitude of the [Ca
2+]i transient is produced by the temporal
and spatial summation of Ca
2+ sparks activated by ICa during the
AP. The amplitude of the [Ca
2+]i transient in adult ventricular
myocytes is graded by the amplitude of ICa, which determines the
probability of Ca
2+ spark recruitment during an AP.
Although hESC-CMs are known to exhibit [Ca
2+]i transients
and express key Ca
2+ handling proteins, including SERCA2b, the
Na
+/Ca
2+ exchanger, and RyR2, there has been considerable
controversy as to the fundamental mechanisms of excitation-
contraction coupling in these cells [43–46]. For example, Dolnikov
et al [47] concluded that essentially all of the [Ca
2+]i transient rise
observed in hESC-CMs results from trans-sarcolemmal entry via
calcium channels and that these cells have little or no release from
Figure 6. Ca
2+ sparks in hESC-CMs and hFVMs. A. Confocal images of Ca
2+ sparks in typical hESC-CMs and hFVMs. The traces to the right of
each image show the time-course of [Ca
2+]i in each Ca
2+ spark site (red trace: hESC-CM, black trace: hFVM). Histograms of the amplitude (B), decay
time to 50% amplitude (T50) (C), and time-to-peak (D) for Ca
2+ sparks in hESC-CMs (red bars, upper) and hFVMs (black bars, lower). E. Bar graph
indicating the rate of Ca
2+ spark occurrence in hESC-CMs and hFVMs. * p,0.05.
doi:10.1371/journal.pone.0005407.g006
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2+stores. By contrast, Satin et al [48] recently reported
that hESC-CMs do exhibit caffeine- and ryanodine-sensitive SR
Ca
2+stores, even at early stages (e.g. as soon as 2 days following the
appearance of spontaneous beating activity). A third group, Liu et
al. [45], also found evidence for functional SR Ca
2+stores in
hESC-CMs, albeit only in a minority of cardiomyocytes. Of note,
all three groups largely relied on hESC-CMs generated using the
‘‘historical’’ method of embryoid body differentiation (i.e. the
formation of spontaneously differentiating three-dimensional
aggregates in high fetal calf serum (FCS)). The present study is
the first to examine intracellular Ca
2+ signaling in hESC-CMs
resulting from our recently reported guided differentiation
protocol (involving serial activin A and BMP-4 under serum-free,
monolayer culture conditions). This method results in preparations
of substantially higher cardiac purity (typically .60% cardiomy-
ocytes, versus ,1% cardiomyocytes via embryoid body differen-
tiation), greatly facilitating biophysical studies with hESC-CMs,
but it could in principle result in cardiomyocytes with a different
functional phenotype. For example, FCS is known to retard
cardiac differentiation [49], so its elimination in our protocol could
conceivable promote a greater degree of maturation.
Here, we report that that hESC-CMs produce Ca
2+ sparks and
exhibit robust ICa and [Ca
2+]i transients. ICa density in hESC-CM
is similar to that of hFVM as well as adult human, mouse, and rat
ventricular myocytes [31,50,51]. Note that the capacitance — an
indicator of cell surface area — of hESC-CMs and hFVMs is
,20–25 pF, which is roughly 5–10-fold smaller than that of adult
ventricular myocytes (which typically range between 100–200 pF
[52]). Collectively, these data suggest that ICa density is established
early in the differentiation of ventricular cardiomyocytes and that,
during development, myocyte hypertrophy is accompanied by a
concomitant increase in L-type Ca
2+ channel expression (presum-
ably Cav1.2) that leads to a relatively stable ICa density throughout
development.
The findings in our study, which is the first to directly examine
the relationship between ICa and [Ca
2+]i transients in hESC-CMs,
are consistent with a model in which activation of SR Ca
2+ release
is tightly regulated by Ca
2+ signals via L-type Ca
2+ channels
during EC coupling. The data supporting this model are
compelling. First,C a
2+ influx via functional L-type Ca
2+ channels
is necessary for EC coupling in hESC-CMs. Second,C a
2+ influx via
L-type Ca
2+ channels activate SR Ca
2+ release in these cells,
thereby producing a global increase in [Ca
2+]i that triggers
contraction. Third,S RC a
2+ release is not all-or-none in hESC-
CMs. Instead, as in adult ventricular myocytes [32,33], SR Ca
2+
release is finely graded by the amplitude of the L-type Ca
2+
current during EC coupling. Fourth, large [Ca
2+]i transients were
evoked by tail ICa during repolarization from +100 mV to
270 mV. Fifth, EC coupling gain is larger at negative potentials
where ICa is small (i.e. 240 mV), but the driving force for Ca
2+
influx is large, than at more positive potentials in which ICa is
maximal (i.e. 0 mV), but the driving force for Ca
2+ entry is lower.
Sixth, RyR2 and L-type Ca
2+ channels co-localize in specific
regions of the sarcolemma of hESC-CMs. Collectively, these
findings strongly indicate that the establishment of tight, local
control of EC coupling is an early event in the development of
human cardiomyocytes. Note that this conclusion distinguishes
hESC-CMs from developing cardiomyocytes in model species,
including mice [17,20–22], rats [53,54], and rabbits [55,56], in
which such adult-like mechanisms of EC coupling have not
generally been observed. Future studies to further investigate these
species differences are clearly warranted (and ideally should
include larger, slower-rated animal models, which we speculate
may more closely approximate developing human cardiomyo-
cytes).
As with the magnitude and kinetics of the ICa, we found that the
amplitude of the evoked [Ca
2+]i transient in hESC-CMs was
similar to that of hFVMs as well as adult human [57], mouse [27],
and rat ventricular myocytes [6]. Our data suggest that a
Table 2. Ca
2+ spark parameters in hESC-derived and fetal
ventricular cardiomyocytes.
Parameter
hESC-CMs
(n=10 cells) hFVMs (n=7 cells)
Frequency (Hz) Mean=0.4560.17** 1.7660.44
Amplitude (F/F0) Median=1.7* Median=2.0
Range=1.1–3.8 Range=1.2–2.45
(n=36 events) (n=86 events)
tdecay (ms) Median=96 Median=85
Range=18–312 Range=24–264
Time-to-peak (ms) Median=38* Median=28
Range=10–160 Range=9–112
Width at 50% peak amplitude (mm) Mean=1.960.1 Mean=1.960.6
**P,0.01.
*P,0.05 hESC-CMs vs. hFVMs.
doi:10.1371/journal.pone.0005407.t002
Figure 7. Higher SR Ca
2+ load in hFVMs than in hESC-CMs. A.
Line-scan images showing AP-evoked and caffeine-induced [Ca
2+]i
transients in hESC-CMs (upper image) and hFVMs (lower image).
Delivery of the 20 mM caffeine is indicated by the arrows. B. Scatter plot
of the amplitude of the caffeine-induced [Ca
2+]i transient in hFVMs and
hESC-CMs. The horizontal bars in the plot show the mean6SEM of the
caffeine-induced [Ca
2+]i transient in each experimental group. * p,0.05.
doi:10.1371/journal.pone.0005407.g007
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2+ influx and SR Ca
2+ release (presumably via
Ca
2+ sparks, but see below) translates into a global [Ca
2+]i
transient during the physiological AP in hESC-CMs. Interestingly,
the relative contribution of ICa (<20%) and the SR (<80%) to the
[Ca
2+]i transient in these cells is similar to that of adult human
ventricular myocytes [57]. These observations suggest that the
amplitude and relative contributions of Ca
2+ influx and release
from intracellular release are established early in cardiac
biogenesis and remain stable throughout development. Multiple
factors come into play in the generation of the [Ca
2+]i transient in
ventricular myocytes, including the amount of Ca
2+ influx, SR
Ca
2+ release, the buffering capacity of the cell as well as the rate
and capacity of Ca
2+ extrusion, and SR Ca
2+ re-sequestration
mechanisms. For example, while the absolute values for cytosolic
buffering capacity, accessible volume, Ca
2+ influx and SR Ca
2+
release likely differ between hESC-CMs, hFVMs, and adult
ventricular myocytes, it is clear their relative proportions lead to
comparable AP-evoked changes in [Ca
2+]i in these cells.
hESC-CMs and hFVMs also showed Ca
2+ sparks, and their
sparks were similar in amplitude, duration, and spatial spread to
those reported in adult cardiomyocytes [6,58]. Our data suggests
that, just as ICa appears fairly early in the development of ESC-
CMs [59,60], hESC-CMs at an early stage of maturation possess
functional CRUs capable of producing adult-like Ca
2+ sparks. We
infer that this early development of CRUs is also likely to be true
in human heart development in situ.C a
2+ spark rate was lower in
hESC-CMs than in hFVMs presumably because SR Ca
2+ load
was higher in hESC-CMs than in hFVMs these cells [38]. The
latter data raise an interesting conundrum: How can hFVMs have
larger SR Ca
2+ load than hESC-CMs, but Ca
2+ sparks and whole-
cell [Ca
2+]i of similar amplitude? Our data do not provide an
answer to this difficult question. One intriguing possibility is that
the number of RyRs underlying a Ca
2+ spark differs between
hESC-CMs and hFVMs. Thus, while the total Ca
2+ flux through
each RyR channel may be smaller (due to lower SR Ca
2+ load) in
hESC-CMs than in hFVMs, a larger number of these channels per
CRU in hESC-CMs results in Ca
2+ sparks of similar amplitude in
both cell types. If correct, this implies that, while hESC-CMs have
functional CRUs capable of producing Ca
2+ sparks, the
development of these units is likely incomplete. Future studies
should examine the mechanisms underlying the development of
CRUs and Ca
2+ sparks in hESC-CMs in more detail.
The Kamp [61] and Mummery [46] groups have reported that
hESC-CMs are electrophysiologically diverse and include myo-
cytes with distinct pacemaker/nodal-like and ‘‘working’’ (atrial
and ventricular chamber- like) AP properties. While it would be of
considerable interest to correlate hESC-CM cardiac subtype with
the mechanisms of EC-coupling, this is unfortunately technically
challenging and so was not performed in the present study.
However, in separate current-clamp studies using the same cell
preparations, we found that ,70% (11 of 16) of cells exhibited a
‘‘working’’, ventricular-like AP phenotype, with the balance
showing nodal-like APs (data not shown). Thus, we expect that
the vast majority of recordings in this study were obtained with
ventricular-like cardiomyocytes. Interestingly, unlike our AP data,
we found the EC-coupling parameters in these cells to be highly
homogenous (i.e. with a unimodal distribution), inviting specula-
tion that EC-coupling mechanisms may be similar across cardiac
subtypes at this developmental stage. We plan to revisit this issue in
more detail in future work.
To conclude, our data clearly indicate that there is a close
relationship between ICa and [Ca
2+]i in hESC-CMs. Furthermore,
our findings support the view that tight, presumably local, control
of EC coupling is an early event in human cardiac development.
Note that this conclusion distinguishes hESC-CMs from develop-
ing cardiomyocytes in model species, including mice [17,20–22],
rats [53,54], and rabbits [55,56], in which such adult-like
mechanisms of EC coupling have not generally been observed.
Finally, based on our findings, we speculate that it is total number
of L-type Ca
2+ channels and RyRs—not their density or coupling
strength—that changes during the maturation of human cardio-
myocytes.
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